Perspective Therapeutics (CATX) Accumulated Expenses (2011 - 2026)
Perspective Therapeutics (CATX) posted Accumulated Expenses of $3.9 million for Q1 2026, down 48.24% sequentially from $7.5 million in Q4 2025, and up 33.1% YoY from $2.9 million in Q1 2025.
Perspective Therapeutics (CATX) Accumulated Expenses (2011 - 2026) Analysis & Trends
Perspective Therapeutics has reported Accumulated Expenses for 16 years, with the latest figure at $3.9 million in Q1 2026.
- Quarterly Accumulated Expenses rose 33.1% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 33.1% YoY) and the FY2025 annual result came in at $7.5 million, up 36.71% from the prior year.
- Accumulated Expenses retreated to $3.9 million in Q1 2026 per CATX's latest filing, from $7.5 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $7.5 million in Q4 2025 and troughed at $150000.0 in Q2 2022.
- A 5-year average of $2.7 million and a median of $2.6 million in 2024 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses retreated 10.04% in 2022, then jumped 1439.91% in 2023.
- Over 5 years, Accumulated Expenses stood at $233000.0 in 2022, then surged by 1439.91% to $3.6 million in 2023, then surged by 52.68% to $5.5 million in 2024, then soared by 36.71% to $7.5 million in 2025, then sank by 48.24% to $3.9 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $3.9 million, $7.5 million, and $6.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 396.34 Mn | 396.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.97 Mn |
| Mar 31, 2026 | 3.88 Mn |
| Dec 31, 2025 | 7.49 Mn |
| Sep 30, 2025 | 6.71 Mn |
| Jun 30, 2025 | 5.04 Mn |
| Mar 31, 2025 | 2.91 Mn |
| Dec 31, 2024 | 5.48 Mn |
| Sep 30, 2024 | 3.98 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Dec 31, 2023 | 3.59 Mn |
| Sep 30, 2023 | 311,000.00 |
| Jun 30, 2023 | 684,000.00 |
| Mar 31, 2023 | 354,000.00 |
| Dec 31, 2022 | 233,000.00 |
| Sep 30, 2022 | 271,000.00 |
| Jun 30, 2022 | 150,000.00 |
| Mar 31, 2022 | 256,000.00 |
| Dec 31, 2021 | 259,000.00 |
| Sep 30, 2021 | 253,000.00 |
| Jun 30, 2021 | 98,000.00 |